Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy

Cell Metabolism

Volumn 19, Issue 5, 2014, Pages 872-882

  Wang, Zhiyu ^a   York, Nathaniel W ^a   Nichols, Colin G ^a   Remedi, Maria S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; INSULIN; ANTIDIABETIC AGENT; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; GLUCOSE BLOOD LEVEL; NERVE PROTEIN; NEUROG3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEDIFFERENTIATION; CELL LOSS; CELL REDIFFERENTIATION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG RESPONSE; GAIN OF FUNCTION MUTATION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN TREATMENT; MOUSE; MOUSE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; TREATMENT RESPONSE; ANIMAL; APOPTOSIS; CELL DIFFERENTIATION; DISEASE MODEL; DRUG EFFECTS; METABOLISM;

ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MICE; NERVE TISSUE PROTEINS;

EID: 84900330718     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2014.03.010     Document Type: Article

References (58)

1. E. Ahlqvist, T.S. Ahluwalia, and L. Groop Genetics of type 2 diabetes Clin. Chem. 57 2011 241 254
2. B. Ahrén Type 2 diabetes, insulin secretion and beta-cell mass Curr. Mol. Med. 5 2005 275 286
3. M. Alvarsson, G. Sundkvist, I. Lager, M. Henricsson, K. Berntorp, E. Fernqvist-Forbes, L. Steen, G. Westermark, P. Westermark, T. Orn, and V. Grill Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients Diabetes Care 26 2003 2231 2237
4. M. Alvarsson, G. Sundkvist, I. Lager, K. Berntorp, E. Fernqvist-Forbes, L. Steen, T. Orn, M.A. Holberg, N. Kirksaether, and V. Grill Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up Diabetes Obes. Metab. 10 2008 421 429
5. 2+ signalling, glucose metabolism and insulin secretion in a murine model of K(ATP) channel-induced neonatal diabetes mellitus Diabetologia 54 2011 1087 1097
6. E. Bernal-Mizrachi, B. Wice, H. Inoue, and M.A. Permutt Activation of serum response factor in the depolarization induction of Egr-1 transcription in pancreatic islet beta-cells J. Biol. Chem. 275 2000 25681 25689
7. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, and P.C. Butler Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 2003 102 110
8. P.C. Butler, J.J. Meier, A.E. Butler, and A. Bhushan The replication of beta cells in normal physiology, in disease and for therapy Nat. Clin. Pract. Endocrinol. Metab. 3 2007 758 768
9. M. Cnop, N. Welsh, J.C. Jonas, A. Jörns, S. Lenzen, and D.L. Eizirik Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities Diabetes 54 Suppl 2 2005 S97 S107
10. S. Del Prato, C. Bianchi, and P. Marchetti Beta-cell function and anti-diabetic pharmacotherapy Diabetes Metab. Res. Rev. 23 2007 518 527
11. S.E. Flanagan, S. Clauin, C. Bellanné-Chantelot, P. de Lonlay, L.W. Harries, A.L. Gloyn, and S. Ellard Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism Hum. Mutat. 30 2009 170 180
12. C.A. Girard, F.T. Wunderlich, K. Shimomura, S. Collins, S. Kaizik, P. Proks, F. Abdulkader, A. Clark, V. Ball, and L. Zubcevic et al. Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes J. Clin. Invest. 119 2009 80 90
13. A.L. Gloyn, E.R. Pearson, J.F. Antcliff, P. Proks, G.J. Bruining, A.S. Slingerland, N. Howard, S. Srinivasan, J.M.C.L. Silva, and J. Molnes et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes N. Engl. J. Med. 350 2004 1838 1849
14. R.H. Greenwood, R.F. Mahler, and C.N. Hales Improvement in insulin secretion in diabetes after diazoxide Lancet 1 1976 444 447
15. G. Gu, J. Dubauskaite, and D.A. Melton Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors Development 129 2002 2447 2457
16. S. Guo, C. Dai, M. Guo, B. Taylor, J.S. Harmon, M. Sander, R.P. Robertson, A.C. Powers, and R. Stein Inactivation of specific β cell transcription factors in type 2 diabetes J. Clin. Invest. 2013 10.1172/JCI65390 Published online July 1, 2013
17. J.J. Heit, A.A. Apelqvist, X. Gu, M.M. Winslow, J.R. Neilson, G.R. Crabtree, and S.K. Kim Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function Nature 443 2006 345 349
18. K.Y. Hur, H.S. Jung, and M.S. Lee Role of autophagy in β-cell function and mass Diabetes Obes. Metab. 12 Suppl 2 2010 20 26
19. H. Ilkova, B. Glaser, A. Tunçkale, N. Bagriaçik, and E. Cerasi Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment Diabetes Care 20 1997 1353 1356
20. U.S. Jhala, G. Canettieri, R.A. Screaton, R.N. Kulkarni, S. Krajewski, J. Reed, J. Walker, X. Lin, M. White, and M. Montminy cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2 Genes Dev. 17 2003 1575 1580
21. J.C. Jonas, A. Sharma, W. Hasenkamp, H. Ilkova, G. Patanè, R. Laybutt, S. Bonner-Weir, and G.C. Weir Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes J. Biol. Chem. 274 1999 14112 14121
22. J.C. Jonas, M. Bensellam, J. Duprez, H. Elouil, Y. Guiot, and S.M. Pascal Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes Diabetes Obes. Metab. 11 Suppl 4 2009 65 81
23. Y.I. Kitamura, T. Kitamura, J.P. Kruse, J.C. Raum, R. Stein, W. Gu, and D. Accili FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction Cell Metab. 2 2005 153 163
24. D.R. Laybutt, M. Glandt, G. Xu, Y.B. Ahn, N. Trivedi, S. Bonner-Weir, and G.C. Weir Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes J. Biol. Chem. 278 2003 2997 3005
25. R. Lupi, and S. Del Prato Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences Diabetes Metab. 34 Suppl 2 2008 S56 S64
26. D.R. Matthews, C.A. Cull, I.M. Stratton, R.R. Holman, and R.C. Turner UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group Diabet. Med. 15 1998 297 303
27. C.G. Nichols, and M.S. Remedi The diabetic β-cell: hyperstimulated vs. hyperexcited Diabetes Obes. Metab. 14 Suppl 3 2012 129 135
28. E.M. Nielsen, L. Hansen, B. Carstensen, S.M. Echwald, T. Drivsholm, C. Glümer, B. Thorsteinsson, K. Borch-Johnsen, T. Hansen, and O. Pedersen The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes Diabetes 52 2003 573 577
29. C.J. Nolan, and M. Prentki The islet beta-cell: fuel responsive and vulnerable Trends Endocrinol. Metab. 19 2008 285 291
30. C.J. Nolan, P. Damm, and M. Prentki Type 2 diabetes across generations: from pathophysiology to prevention and management Lancet 378 2011 169 181
31. E.R. Pearson, I. Flechtner, P.R. Njølstad, M.T. Malecki, S.E. Flanagan, B. Larkin, F.M. Ashcroft, I. Klimes, E. Codner, V. Iotova Neonatal Diabetes International Collaborative Group Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations N. Engl. J. Med. 355 2006 467 477
32. V. Poitout, and R.P. Robertson Glucolipotoxicity: fuel excess and beta-cell dysfunction Endocr. Rev. 29 2008 351 366
33. S. Porat, N. Weinberg-Corem, S. Tornovsky-Babaey, R. Schyr-Ben-Haroush, A. Hija, M. Stolovich-Rain, D. Dadon, Z. Granot, V. Ben-Hur, and P. White et al. Control of pancreatic β cell regeneration by glucose metabolism Cell Metab. 13 2011 440 449
34. M. Prentki, and C.J. Nolan Islet beta cell failure in type 2 diabetes J. Clin. Invest. 116 2006 1802 1812
35. S. Puri, and M. Hebrok Diabetic β cells: to be or not to be? Cell 150 2012 1103 1104
36. E. Qvigstad, M. Kollind, and V. Grill Nine weeks of bedtime diazoxide is well tolerated and improves beta-cell function in subjects with Type 2 diabetes Diabet. Med. 21 2004 73 76
37. J. Rahier, Y. Guiot, R.M. Goebbels, C. Sempoux, and J.C. Henquin Pancreatic beta-cell mass in European subjects with type 2 diabetes Diabetes Obes. Metab. 10 Suppl 4 2008 32 42
38. R.B. Reinert, J. Kantz, A.A. Misfeldt, G. Poffenberger, M. Gannon, M. Brissova, and A.C. Powers Tamoxifen-induced Cre-loxP recombination is prolonged in pancreatic islets of adult mice PLoS ONE 7 2012 e33529
39. M.S. Remedi, and C.G. Nichols Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells PLoS Med. 5 2008 e206
40. M.S. Remedi, H.T. Kurata, A. Scott, F.T. Wunderlich, E. Rother, A. Kleinridders, A. Tong, J.C. Brüning, J.C. Koster, and C.G. Nichols Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus Cell Metab. 9 2009 140 151
41. M.S. Remedi, S.E. Agapova, A.K. Vyas, P.W. Hruz, and C.G. Nichols Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes Diabetes 60 2011 2515 2522
42. C.J. Rhodes Type 2 diabetes-a matter of beta-cell life and death? Science 307 2005 380 384
43. M.J. Riedel, D.C. Steckley, and P.E. Light Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes Hum. Genet. 116 2005 133 145
44. R.P. Robertson, J. Harmon, P.O. Tran, and V. Poitout Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes Diabetes 53 Suppl 1 2004 S119 S124
45. H. Sakuraba, H. Mizukami, N. Yagihashi, R. Wada, C. Hanyu, and S. Yagihashi Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients Diabetologia 45 2002 85 96
46. K. Shimomura, F. Hörster, H. de Wet, S.E. Flanagan, S. Ellard, A.T. Hattersley, N.I. Wolf, F. Ashcroft, and F. Ebinger A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain Neurology 69 2007 1342 1349
47. C. Talchai, S. Xuan, T. Kitamura, R.A. DePinho, and D. Accili Generation of functional insulin-producing cells in the gut by Foxo1 ablation Nat. Genet. 44 2012 406 412 S401
48. C. Talchai, S. Xuan, H.V. Lin, L. Sussel, and D. Accili Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure Cell 150 2012 1223 1234
49. Y. Tanaka, P.O. Tran, J. Harmon, and R.P. Robertson A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity Proc. Natl. Acad. Sci. USA 99 2002 12363 12368
50. R. Torella, T. Salvatore, D. Cozzolino, R. Giunta, A. Quatraro, and D. Giugliano Restoration of sensitivity to sulfonylurea after strict glycaemic control with insulin in non-obese type 2 diabetic subjects Diabete Metab. 17 1991 443 447
51. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
52. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
53. D.T. Villareal, J.C. Koster, H. Robertson, A. Akrouh, K. Miyake, G.I. Bell, B.W. Patterson, C.G. Nichols, and K.S. Polonsky Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance Diabetes 58 2009 1869 1878
54. B.L. Wajchenberg beta-cell failure in diabetes and preservation by clinical treatment Endocr. Rev. 28 2007 187 218
55. S. Wang, J.N. Jensen, P.A. Seymour, W. Hsu, Y. Dor, M. Sander, M.A. Magnuson, P. Serup, and G. Gu Sustained Neurog3 expression in hormone-expressing islet cells is required for endocrine maturation and function Proc. Natl. Acad. Sci. USA 106 2009 9715 9720
56. N. Weinberg, L. Ouziel-Yahalom, S. Knoller, S. Efrat, and Y. Dor Lineage tracing evidence for in vitro dedifferentiation but rare proliferation of mouse pancreatic beta-cells Diabetes 56 2007 1299 1304
57. J. Weng, Y. Li, W. Xu, L. Shi, Q. Zhang, D. Zhu, Y. Hu, Z. Zhou, X. Yan, and H. Tian et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial Lancet 371 2008 1753 1760
58. X. Xu, J. D'Hoker, G. Stangé, S. Bonné, N. De Leu, X. Xiao, M. Van de Casteele, G. Mellitzer, Z. Ling, and D. Pipeleers et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas Cell 132 2008 197 207